Johns Hopkins ABX Guide
Viekira Pak
INDICATIONS
FDA
FDA
- Viekira Pak: combination pack of four medications.
- Ombitasvir/paritaprevir/ritonavir and dasabuvir
- Indicated for treatment of hepatitis C virus (HCV) genotype 1 (1a or 1b) infection with or without the addition of ribavirin
- Viekira Pak has been studied in patients with HIV co-infection, liver transplant recipients and those with compensated cirrhosis and/or mild hepatic impairment
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 2, 2017
Citation
Dzintars, Kathryn. "Viekira Pak." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540656/5/Viekira_Pak.
Dzintars K. Viekira Pak. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540656/5/Viekira_Pak. Accessed October 3, 2024.
Dzintars, K. (2017). Viekira Pak. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540656/5/Viekira_Pak
Dzintars K. Viekira Pak [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2024 October 03]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540656/5/Viekira_Pak.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Viekira Pak
ID - 540656
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2017/03/02/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540656/5/Viekira_Pak
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
